Neurology
Latest News
Neurologic disease eventually affects half of women and one-third of men
Around one-half of women and one-third of men are likely to develop either stroke, dementia, or parkinsonism during their lifetime.
FDA/CDC
Emgality approved for migraine prevention in adults
The calcitonin gene–related peptide antagonist was tested in both episodic and chronic migraine.
Conference Coverage
Signs point to growing abuse of gabapentinoids in the U.S.
LAS VEGAS – Several states have made gabapentin a Schedule V controlled substance while others have mandatory reporting of its dispensing and...
Latest News
Confirmed: Growth in overdose deaths is exponential
Opioid epidemic appears to be “the most recent manifestation of a more fundamental, longer-term process.”
FDA/CDC
FDA approves Ajovy for migraine prevention
The injection is available in a 225-mg dose monthly or a 675-mg dose every 3 months.
Conference Coverage
More than half of urine drug screens showed improper medication use
LAS VEGAS – One sample in every five showed a combination of opioids and benzodiazepines, at least one of which was an unprescribed medication.
Conference Coverage
Intensive Blood Pressure Management May Reduce the Risk of MCI
CHICAGO—Lowering systolic blood pressure to a target of 120 mm Hg or less in people with cardiovascular risk factors reduces the risk of mild...
Article
Self-management intervention for epilepsy achieves health improvements
A remote, self-management intervention for individuals with epilepsy improved negative health event rates and quality of life.
News
Declining lung function linked to heart failure, stroke
Cardiologists and pulmonologists should collaborate to better identify the relationship between lung function decline and early CV disease...
Conference Coverage
Mindfulness training for migraine just beginning to gather steam
SAN FRANCISCO – “The effects of mindfulness by and large rivaled those for medication alone,” says researcher Frank Andrasik, PhD.